By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Spectranetics Corporation 

96 Talamine Court
Colorado Springs  Colorado  80907  U.S.A.
Phone: 1-800-633-0960 Fax: 719-633-2248


Medical Device

Company News
Spectranetics (SPNC) Names Stacy McMahan Chief Financial Officer 8/28/2015 7:18:54 AM
Spectranetics (SPNC) To Present At The Canaccord Genuity Growth Conference 7/31/2015 7:29:33 AM
Spectranetics (SPNC) Completes Enrollment In ILLUMENATE Pivotal Study To Assess Safety And Efficacy Of Stellarex Drug-Coated Balloon Technology 7/29/2015 8:06:00 AM
Spectranetics (SPNC) Reports Second Quarter Financial Results 7/24/2015 7:45:23 AM
Spectranetics (SPNC) To Hold 2015 Second Quarter Financial Results Conference Call On July 23, 2015 7/10/2015 7:17:36 AM
Spectranetics (SPNC) Receives FDA 510(k) Clearance for Larger Diameter AngioSculpt Scoring Balloon Enabling Entry Into New Markets 6/25/2015 6:16:11 AM
Spectranetics Corporation (SPNC) Release: EXCITE ISR Landmark Study Proves Durability At 12-Months, Findings Validate Safety And Superiority Of Laser Atherectomy With PTA Vs. PTA Alone; Data Presented At NCVH 2015 5/28/2015 8:22:24 AM
Spectranetics Corporation (SPNC) To Participate In Upcoming Investor Conferences 5/1/2015 10:16:31 AM
Spectranetics Corporation (SPNC) Accelerates Investment In Stellarex Drug- Coated Balloon Platform For Treatment Of Below The Knee (BTK) Peripheral Vascular Disease 4/23/2015 7:19:52 PM
Spectranetics Corporation (SPNC) Achieves First Quarter 2015 Revenue Of $57.4 Million 4/23/2015 7:15:00 PM